Min Xia
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
- Oncology 8
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Chris Saris (2 shared papers)Roshni Basu (1 shared paper)Mohd Azam (1 shared paper)Paul Tempst (1 shared paper)Christian Schindler (1 shared paper)James N. Ihle (1 shared paper)Hediye Erdjument‐Bromage (1 shared paper)Frederick W. Quelle (1 shared paper)
- Journals
- Blood (5 papers)International Journal of Technology Management (2 papers)Oncology Reports (1 paper)Hematological Oncology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Min Xia
26 papers receiving 720 citations
Peers
Comparison fields: 5 of 70
- Hematology 188
- Genetics 132
- Oncology 319
- Immunology 244
- Cancer Research 122
Countries citing papers authored by Min Xia
This map shows the geographic impact of Min Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xia more than expected).
Fields of papers citing papers by Min Xia
This network shows the impact of papers produced by Min Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xia. The network helps show where Min Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 310 | |
| 2 | 1995 | 136 | |
| 3 | 1995 | 59 | |
| 4 | 2018 | 46 | |
| 5 | 2006 | 41 | |
| 6 | 2021 | 26 | |
| 7 | 1990 | 20 | |
| 8 | 2015 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2024 | 11 | |
| 11 | 2018 | 11 | |
| 12 | [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease]. | 2006 | 7 |
| 13 | 2025 | 6 | |
| 14 | 2020 | 6 | |
| 15 | [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease]. | 2006 | 6 |
| 16 | 2024 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2022 | 3 |
About Min Xia
Min Xia is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Hematology, having authored 30 papers that have together received 736 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Economic Development and Digital Transformation (2 papers), Cancer-related Molecular Pathways (2 papers), Immune Cell Function and Interaction (2 papers), Platelet Disorders and Treatments (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Hematology (188 citations), Genetics (132 citations), Oncology (319 citations), Immunology (244 citations) and Cancer Research (122 citations). Min Xia has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Chris Saris, Roshni Basu, Mohd Azam, Paul Tempst, Christian Schindler, James N. Ihle, Hediye Erdjument‐Bromage, Frederick W. Quelle, Frederick A. Fletcher and Patricia McElroy. Their work appears in journals such as Blood, International Journal of Technology Management, Oncology Reports, Hematological Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.